Turn Therapeutics Inc. (TTRX)
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye.
$8.25+0.11%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+10.7%
The outlook
Turn Therapeutics Inc. currently reads as bullish based on strong buy — 1.0 avg of 1 analysts, above its 50- & 200-day averages, 24% of the way from its 52-week low to high, avg target +215% vs current price. This is a snapshot of current market data, not a forecast.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 1 analysts
Price trendAbove its 50- & 200-day averages
52-week range24% of the way from its 52-week low to high
Price targetAvg target +215% vs current price
Market cap
$245.8M
52-wk high
$26.50
52-wk low
$2.57
50-day avg
$7.00
200-day avg
$4.66
Trailing P/E
—